A prospective study of bone mineral density changes in patients during chemotherapy for advanced solid tumors

A prospective study of bone mineral density changes in patients during chemotherapy for advanced solid tumors - Bone density change study during chemotherapy for advanced solid tumors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057468

Enrollment

100

Registered

2025-04-01

Start date

2024-06-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A prospective study of bone mineral density changes in patients during chemotherapy for advanced solid tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Solid tumor patients undergoing chemotherapy in which steroids are administered for antiemetic purposes 2) The patients who can assess bone density periodically 3) Adult patient aged over 20 years 4) The patient who have been fully informed of the study and who have given written consent of their own free will

Exclusion criteria

Exclusion criteria: 1) The patients for whom regular bone density testing is not possible 2) THe patients younger than 20 years of age 3) The patients diagnosed with osteoporosis by bone density test 4) The patients with metastatic bone tumors 5) The patients who are regularly using steroids 6) The patients who judged a study doctor to be inappropriate as subjects

Design outcomes

Primary

Measure	Time frame
Rate of decrease in bone mineral density after 3 months of chemotherapy	—

Countries

Japan

Contacts

Public ContactHideaki Okada

Medical Oncology and Hematology Medical Oncology and Hematology

shumei_oka@joy.ocn.ne.jp079-289-5080

Outcome results